Cargando…

Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands

BACKGROUND: Group B Streptococcus (GBS) is the leading cause of neonatal sepsis and meningitis worldwide. We aimed to estimate the current burden of neonatal invasive GBS disease in the Netherlands, as a first step in providing an evidence base for policy makers on the potential benefits of a future...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Gier, Brechje, van Kassel, Merel N., Sanders, Elisabeth A. M., van de Beek, Diederik, Hahné, Susan J. M., van der Ende, Arie, Bijlsma, Merijn W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508726/ https://www.ncbi.nlm.nih.gov/pubmed/31071191 http://dx.doi.org/10.1371/journal.pone.0216749

Ejemplares similares

Prematurity Modifies the Risk of Long-term Neurodevelopmental Impairments After Invasive Group B Streptococcus Infections During Infancy in Denmark and the Netherlands
por: Horváth-Puhó, Erzsébet, et al.
Publicado: (2021)

Increasing incidence of group B streptococcus neonatal infections in the Netherlands is associated with clonal expansion of CC17 and CC23
por: Jamrozy, Dorota, et al.
Publicado: (2020)

Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: 3 Decades of National Meningitis Surveillance in The Netherlands
por: Koelman, Diederik L H, et al.
Publicado: (2020)

Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study
por: Horváth-Puhó, Erzsébet, et al.
Publicado: (2021)

Listeria monocytogenes meningitis in the Netherlands, 1985–2014: A nationwide surveillance study
por: Koopmans, Merel M., et al.
Publicado: (2017)

Population genomics of Group B Streptococcus reveals the genetics of neonatal disease onset and meningeal invasion
por: Chaguza, Chrispin, et al.
Publicado: (2022)

Incidence and mortality of necrotizing fasciitis in The Netherlands: the impact of group A Streptococcus
por: Nawijn, Femke, et al.
Publicado: (2021)

Out-of-season increase of puerperal fever with group A Streptococcus infection: a case–control study, Netherlands, July to August 2018
por: van den Boogaard, Jossy, et al.
Publicado: (2020)

Short-term and long-term risk of mortality and neurodevelopmental impairments after bacterial meningitis during infancy in children in Denmark and the Netherlands: a nationwide matched cohort study
por: Snoek, Linde, et al.
Publicado: (2022)

Neonatal early-onset infections: Comparing the sensitivity of the neonatal early-onset sepsis calculator to the Dutch and the updated NICE guidelines in an observational cohort of culture-positive cases
por: Snoek, Linde, et al.
Publicado: (2022)

Pneumococcal Meningitis in Adults: A Prospective Nationwide Cohort Study Over a 20-year Period
por: Koelman, Diederik L H, et al.
Publicado: (2021)

Streptococcus suis Meningitis: A Systematic Review and Meta-analysis
por: van Samkar, Anusha, et al.
Publicado: (2015)

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2019)

Sex Differences in Long-term Outcomes After Group B Streptococcal Infections During Infancy in Denmark and the Netherlands: National Cohort Studies of Neurodevelopmental Impairments and Mortality
por: van Kassel, Merel N, et al.
Publicado: (2021)

The dynamics of scarlet fever in The Netherlands, 1906–1920: a historical analysis
por: McDonald, Scott A., et al.
Publicado: (2022)

Sequencing of the variable region of rpsB to discriminate between Streptococcus pneumoniae and other streptococcal species
por: Wyllie, Anne L., et al.
Publicado: (2017)

Carriage of Streptococcus pneumoniae 3 Years after Start of Vaccination Program, the Netherlands
por: Spijkerman, Judith, et al.
Publicado: (2011)

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
por: van Iersel, Senna C.J.L., et al.
Publicado: (2023)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden
por: Gonçalves, Bronner P, et al.
Publicado: (2022)

Occupation- and age-associated risk of SARS-CoV-2 test positivity, the Netherlands, June to October 2020
por: de Gier, Brechje, et al.
Publicado: (2020)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

An Analysis of the Sequence Variability of Meningococcal fHbp, NadA and NHBA over a 50-Year Period in the Netherlands
por: Bambini, Stefania, et al.
Publicado: (2013)

Diversification in immunogenicity genes caused by selective pressures in invasive meningococci
por: Kremer, Philip H.C., et al.
Publicado: (2020)

Implementation of a cost-effective strategy to prevent neonatal early-onset group B haemolytic streptococcus disease in the Netherlands
por: Kolkman, Diny GE, et al.
Publicado: (2013)

Community-Acquired Bacterial Meningitis in Alcoholic Patients
por: Weisfelt, Martijn, et al.
Publicado: (2010)

Increase in imported malaria in the Netherlands in asylum seekers and VFR travellers
por: de Gier, Brechje, et al.
Publicado: (2017)

Group B Streptococcus Early-Onset Disease: New Preventive and Diagnostic Tools to Decrease the Burden of Antibiotic Use
por: Nusman, Charlotte M., et al.
Publicado: (2023)

Population Structure of Invasive Streptococcus pneumoniae in the Netherlands in the Pre-Vaccination Era Assessed by MLVA and Capsular Sequence Typing
por: Elberse, Karin E. M., et al.
Publicado: (2011)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Cerebrospinal fluid inflammatory markers in patients with Listeria monocytogenes meningitis
por: Koopmans, Merel M., et al.
Publicado: (2014)

Genetic Variation and Cerebrospinal Fluid Levels of Mannose Binding Lectin in Pneumococcal Meningitis Patients
por: Brouwer, Matthijs C., et al.
Publicado: (2013)

Differences in the Population Structure of Invasive Streptococcus suis Strains Isolated from Pigs and from Humans in the Netherlands
por: Schultsz, Constance, et al.
Publicado: (2012)

Campylobacter Fetus Meningitis in Adults: Report of 2 Cases and Review of the Literature
por: van Samkar, Anusha, et al.
Publicado: (2016)

Evaluation of the surveillance system for invasive meningococcal disease (IMD) in the Netherlands, 2004–2016
por: Brandwagt, Diederik A. H., et al.
Publicado: (2019)

COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021
por: van Ewijk, Catharina E, et al.
Publicado: (2022)

Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022
por: Andeweg, Stijn P, et al.
Publicado: (2023)

Outcome in patients with bacterial meningitis presenting with a minimal Glasgow Coma Scale score
por: Lucas, Marjolein J., et al.
Publicado: (2014)

Community-acquired Bacterial Meningitis in Adults With Cerebrospinal Fluid Leakage
por: ter Horst, Liora, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vuafmq1mvpbfiv57llj06gt9a4